The effect of oral alpha-lipoic acid supplement on nonalcoholic fatty liver disease patients

Not Applicable

• Conditions: on-alcoholic fatty liver disease.; Fatty (change of) liver, not elsewhere classified

• Registration Number: IRCT201511143320N12
• Lead Sponsor: utrition Research Center, Tabriz University of Medical Scienses

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Desire to participate in the study, confirmation of NAFLD with liver Ultrasonography, aged 20-50 years from both gender, body mass index between 30-40 kg/m2, taking 400IU/day vitamin E, moderate physical activity level
Exclusion criteria: Alcohol consumption, smoking, pregnant, lactating and menopausal women, very active subjectes or athletes, hospitalized subjects, suffering from hypertension, cardiovascular diseases, pulmonary diseases, renal diseases, liver transplantation, other acute and chronic liver diseases, biliary system disorders, cancer, Inherited disorders affecting the liver. Receiving Oral Contraceptive Pill (OCP) and antioxidant vitamins unless vitamin E, hypertension and thyroid affecting drugs, statins, inflammation and Insulin sensitivity affecting drugs and Hepatotoxic drugs including phenytoin, amiodarone, levothyroxine, tamoxifen and lithium

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified